Videos

Ajinomoto Althea Launches New Facility

Ajinomoto Althea Launches New Facility

57,000 sq. ft. ADC and Fill/Finish site will have areas dedicated to bioconjugation, formulation, purification, QC, and more

08.29.18
Ajinomoto Althea celebrated its 20th year in operation. Concurrently, Althea held the grand opening of its new state-of-the-art Antibody Drug Conjugate (ADC) and Highly Potent Fill and Finish facility located at 6175 Lusk Blvd, near its existing campus.  

The manufacturing facility includes areas dedicated to bioconjugation, formulation, purification, quality control, and sterile fill and finish including lyophilization.  This 57,000 square foot facility enables Althea to offer clients a simplified manufacturing supply chain service from a single US-based location. Manufacturing ADCs and HPAPIs requires specialized facilities and infrastructure to ensure safe handling of these potent therapeutics. The facility can accommodate early clinical phase through commercially approved programs.  
 
The event celebrated Althea's 20 years of biotechnology development and manufacturing services in San Diego and featured several speakers, including the president of Ajinomoto Co. Inc., the president and chief executive officer of Althea, and the San Diego Mayor, Kevin Faulconer, who commemorated the celebration with a ribbon cutting ceremony. 

Mayor Faulconer said, "For two decades, Althea has made their mark on our City and our region. They help fuel our economy. Their employees volunteer and give back to our communities. And they have attracted global partners like Ajinomoto to invest even more in the San Diego region. This is a story of success – one that is only going to get better and better with this new facility."

Althea president and chief executive officer J. David Enloe Jr. said, "We couldn't think of a better way to celebrate 20 years in San Diego than with the opening of our new facility.  We are extremely proud of the growth the company has experienced over the past two decades and are excited for this next phase of growth with the opening of this new facility, all of which serves our ultimate goal of providing patients across the world with the most cutting edge therapeutics available.  I am also very pleased that we were able to incorporate multiple strategies to ensure we are operating this facility in the most environmentally sustainable means possible.”
 
Related Searches:
Suggested For You

Related Buyers Guide Companies

    Loading, Please Wait..